Feed KURN.SW
KU
Kuros Biosciences AG
KURN.SW · SIX
CHF 21.90 -5.36% (-CHF 1.24)
1M +7.63%
Market Cap CHF 916.6M
P/E Ratio 432.64x
Div. Yield -
ROE -
Bulios Fair Price
CHF 19.64
10.3% downside
Preț actual
CHF 21.9
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile KURN.SW sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Valuation
1 /100
Expensive P/E 432.64x
EV/EBITDA 89.34x
P/B 13.69x
Growth
82 /100
Growing Rev. growth 88.93%
Book val. growth 0.94%
EPS growth N/A
Profitability
31 /100
Weak Gross margin 86.39%
Net margin 1.75%
FCF margin 1.98%
Quality
39 /100
Average ROIC 4.84%
ROA 1.98%
Asset turnover 1.13x
Debt
100 /100
Low Debt/Equity 0.06x
Current ratio 1.96x
Net debt/EBITDA -1.16x
Stability
39 /100
Moderate Beta 0.74x
Rev. volatility 32.48%
Profitable years 1
Întreabă StockBot despre KURN.SW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher T. Fair
Employees
178
Headquarters
Schlieren
Evenimente viitoare
17 MAR.
Earnings
Upcoming earnings report